PMID- 20063549
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20100203
LR  - 20191111
IS  - 1658-3876 (Print)
IS  - 2589-0646 (Linking)
VI  - 1
IP  - 3
DP  - 2008 Jul-Sep
TI  - Cancer incidence among the Bahraini population: a five-year (1998-2002) 
      experience.
PG  - 175-82
AB  - BACKGROUND: Cancer is the second leading cause of death, following cardiovascular 
      diseases, accounting for 12% of annually reported deaths in Bahrain. We 
      determined the epidemiological patterns of malignancies in Bahrain and compared 
      them with those of other Gulf Cooperation Council (GCC) countries and other 
      developed countries. SUBJECTS AND METHODS: Data for the study were obtained from 
      the Bahrain Cancer Registry (BCR) database. The overall and type-specific 5-year 
      average incidence rates were calculated for the years 1998-2002 and derived using 
      the CANREG software formula. The incidence rates for the year 2000 were used for 
      comparing Bahrain with those of other countries in the Arabian Gulf using the 
      statistics of the Gulf Centre for Cancer Registration. RESULTS: During the 5-year 
      period there were 2405 cancer cases in Bahrain (1239 males and 1166 females), 
      with an annual average of 481 cases. The world age-standardized incidence rates 
      (ASR) were 162.3 and 145.2 per 100000 for Bahraini males and females, 
      respectively. Generally, Bahraini men had a higher ASR for most cancer types, and 
      the most common type of cancer was lung for males (35.2 per 100000), followed by 
      bladder (14.5) and prostate (14.3), and breast for females (46.8), followed by 
      lung (12.2) and ovary (7.7). CONCLUSION: Compared to other Gulf countries, 
      Bahrain had higher incidence rates for cancers of the lung, prostate, colorectum, 
      bladder, kidney, pancreas and leukemia among males and for cancers of the breast, 
      lung, bladder, thyroid, uterus and ovary among females. A rising trend in cancer 
      incidence is likely to continue for years or even decades to come.
FAU - Alsayyad, Jamal
AU  - Alsayyad J
AD  - Medical Review Office, Ministry of Health, Manama, Bahrain. JSayyad@health.gov.bh
FAU - Hamadehb, Randah
AU  - Hamadehb R
LA  - eng
PT  - Journal Article
PL  - Saudi Arabia
TA  - Hematol Oncol Stem Cell Ther
JT  - Hematology/oncology and stem cell therapy
JID - 101468532
RPF - Ann Saudi Med. 2007 Jul-Aug;27(4):251-8. PMID: 17684428
EDAT- 2008/07/01 00:00
MHDA- 2008/07/01 00:01
CRDT- 2010/01/13 06:00
PHST- 2010/01/13 06:00 [entrez]
PHST- 2008/07/01 00:00 [pubmed]
PHST- 2008/07/01 00:01 [medline]
AID - S1658-3876(08)50027-6 [pii]
AID - 10.1016/s1658-3876(08)50027-6 [doi]
PST - ppublish
SO  - Hematol Oncol Stem Cell Ther. 2008 Jul-Sep;1(3):175-82. doi: 
      10.1016/s1658-3876(08)50027-6.